MRI should be routine for all patients with localized prostate cancer? | Opinion: No

MRI should be routine for all patients with localized prostate cancer? | Opinion: No

Bibliographic Details
Main Author:	Joel B. Nelson
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia
Series:	International Brazilian Journal of Urology
Subjects:	Magnetic Resonance Imaging Prostatic Neoplasms Diagnosis Watchful Waiting
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000601065&lng=en&tlng=en

Similar Items

MRI should be routine for all patients with localized prostate cancer? | Opinion: Yes
by: Ronaldo Hueb Baroni

The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance
by: Chang Wook Jeong, et al.
Published: (2014-12-01)

Current status of active surveillance in prostate cancer
by: Mun Su Chung, et al.
Published: (2016-01-01)

Midterm MRI Follow-Up of Untreated Enchondroma and Atypical Cartilaginous Tumors in the Long Bones
by: Claudia Deckers, et al.
Published: (2021-08-01)

Super active surveillance for low-risk prostate cancer | Opinion: No
by: Saum Ghodoussipour, et al.

Super active surveillance for low-risk prostate cancer | Opinion: Yes
by: Leonardo O. Reis, et al.

A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up
by: Sang Hun Song, et al.
Published: (2021-01-01)

The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
by: Wan Song, et al.
Published: (2019-11-01)

Predicting Insignificant Prostate Cancer: Analysis of the Pathological Outcomes of Candidates for Active Surveillance according to the Pre-International Society of Urological Pathology (Pre-ISUP) 2014 Era Versus the Post-ISUP2014 Era
by: Mun Su Chung, et al.
Published: (2021-07-01)

Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up
by: Ji Yong Ha, et al.
Published: (2017-05-01)

Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable‐risk prostate cancer
by: Da Huang, et al.
Published: (2023-04-01)

Predictive role of Trimprob associated with multiparametric MRI in the diagnosis of prostate cancer
by: Gustavo Cardoso Guimaraes, et al.

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
by: Hanfeng Wang, et al.
Published: (2017-09-01)

Active surveillance in intermediate risk prostate cancer: is it safe?
by: Nishanth Krishnananthan, et al.
Published: (2016-06-01)

Active surveillance in intermediate risk prostate cancer: is it safe?
by: Henk G. van der Poel, et al.
Published: (2016-06-01)

Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?
by: Publio Cesar Cavalcanti Viana, et al.

Prostate MRI: a national survey of Urologist’s attitudes and perceptions
by: Brandon J. Manley, et al.
Published: (2016-06-01)

Objective value on Apparent diffusion coefficient (ADC) map to categorize the intensity of diffusion-weighted imaging (DWI) restriction for prostate cancer detection on multiparametric prostate MRI
by: Thais Caldara Mussi, et al.

Inflammation appears as high Prostate Imaging–Reporting and Data System scores on prostate magnetic resonance imaging (MRI) leading to false positive MRI fusion biopsy
by: Elizabeth Rourke, et al.
Published: (2019-09-01)

Is it necessary for all patients with suspicious lesions undergo systematic biopsy in the era of MRI-TRUS fusion targeted biopsy?
by: Zhengtong Lv, et al.
Published: (2023-06-01)

Prostate cancer detection using multiparametric 3 – tesla MRI and fusion biopsy: preliminary results
by: Thais Caldara Mussi, et al.

Current Status of “Watch-and-Wait” Rectal Cancer Treatment in Asia-Pacific Countries
by: Jung Wook Huh, et al.
Published: (2020-04-01)

Comparative Performance of Deep Learning and Radiologists for the Diagnosis and Localization of Clinically Significant Prostate Cancer at MRI: A Systematic Review
by: Christian Roest, et al.
Published: (2022-09-01)

Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detection
by: Thais Caldara Mussi, et al.

The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
by: Niranjan J. Sathianathen, et al.
Published: (2018-09-01)

Re-staging and follow-up of rectal cancer patients with MR imaging when “Watch-and-Wait” is an option: a practical guide
by: Inês Santiago, et al.
Published: (2021-08-01)

Magnetic resonance imaging for prostate cancer: Comparative studies including radical prostatectomy specimens and template transperineal biopsy
by: Liam Toner, et al.
Published: (2015-12-01)

Prevalence of prostate cancer in MRI-TRUS fusion biopsy patients with suspected lesion in Multi-Parametric MRI with PI-RADS 2 and 3 who have previously undergone prostate biopsy
by: Katebi K, et al.
Published: (2022-06-01)

Feasibility and impact of using an automated user interface for proton spectroscopy in multiparametric MRI of the prostate
by: Mohamed M. H. Abd Ellah, et al.
Published: (2020-04-01)

A multicenter study of artificial intelligence-aided software for detecting visible clinically significant prostate cancer on mpMRI
by: Zhaonan Sun, et al.
Published: (2023-04-01)

Preoperative histogram parameters of dynamic contrast‐enhanced MRI as a potential imaging biomarker for assessing the expression of Ki‐67 in prostate cancer
by: Yongsheng Zhang, et al.
Published: (2021-07-01)

Magnetic Resonance Image in the diagnosis and evaluation of extra-prostatic extension and involvement of seminal vesicles of prostate cancer: a systematic review of literature and meta-analysis
by: Rogério Cardoso da Silva, et al.
Published: (2013-04-01)

Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI
by: Doo Yong Chung, et al.
Published: (2018-11-01)

Comparison of Sensitivity and Specificity of Biparametric versus Multiparametric Prostate MRI in the Detection of Prostate Cancer in 431 Men with Elevated Prostate-Specific Antigen Levels
by: Filippo Pesapane, et al.
Published: (2021-07-01)

Prostate Cancer: The Role of Multiparametric Magnetic Resonance Imaging
by: João Lopes Dias, et al.
Published: (2015-04-01)

Active surveillance of atypical cartilaginous tumours of bone: short term quality of life measurements
by: Claudia Deckers, et al.
Published: (2023-03-01)

Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
by: Min Ji Jeon, et al.
Published: (2021-08-01)

Promoting the use of the PRECISE score for prostate MRI during active surveillance: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship
by: Francesco Giganti, et al.
Published: (2022-07-01)

How many patients with negative MRI have prostate cancer?
by: V. V. Hvorov, et al.
Published: (2018-12-01)

Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer
by: Francesco Porpiglia, et al.
Published: (2015-02-01)